UBS Lux Equity Fund Biotech USD vs DNB Teknologi

UBS Lux Equity Fund Biotech USD vs DNB Teknologi

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. DNB Teknologi

  • Security

    DNB Teknologi A

  • Fee

    1.14%

  • ISIN

    NO0010337678

  • Holdings

    21

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with DNB Teknologi, we have 31 holdings where Microsoft is the largest holding (9.65), followed by Alphabet (7.95) and Samsung (7.93).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and DNB Teknologi.

UBS Lux Equity Fund Biotech USD DNB Teknologi
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Microsoft Corp
USA
9.65 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Alphabet Inc Class A
USA
7.95 %
3. Moderna Inc
9.21 %
3. Samsung Electronics Co Ltd
South Korea
7.93 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. Nokia Oyj
5.51 %
5. AbbVie Inc
USA
5.52 %
5. Nvidia Corp
USA
4.32 %
6. Gilead Sciences Inc
USA
4.66 %
6. Amazon.com Inc
USA
4.28 %
7. Amgen Inc
4.32 %
7. Meta Platforms A
USA
4.19 %
8. BioNTech SE
4.13 %
8. Ericsson B
Sweden
4.1 %
9. Karuna Therapeutics Inc
3.75 %
9. Mastercard Inc
USA
2.68 %
10. Royalty Pharma Plc
3.28 %
10. Capgemini SE
France
2.17 %
- 11. Visa Inc
USA
2.13 %
- 12. Sony Group Corp
Japan
2.03 %
- 13. Deutsche Telekom AG
Germany
1.94 %
- 14. Datadog Inc
USA
1.85 %
- 15. STMicroelectronics NV
Switzerland
1.79 %
- 16. SAP SE
Germany
1.75 %
- 17. Oracle Corp
1.58 %
- 18. Check Point Software Technologies Ltd
Israel USA
1.57 %
- 19. Take-Two Interactive Software Inc
USA
1.49 %
- 20. Adobe Inc
USA
1.33 %
- 21. Nordic Semiconductor ASA
Norway
1.29 %

The list of fund holdings was last updated on April 17, 2025.